Article metrics

Download PDFPDF

718 Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023254029
Dec 2023236017
Jan 2024139013
Feb 202484013
Mar 2024100012
Apr 2024146021
May 2024118017
Jun 2024105017
Jul 2024100019
Aug 202482011
Sep 2024165018
Oct 2024158017
Nov 2024132024
Dec 202480019
Jan 2025138015
Feb 202522014
Mar 20250030
Apr 20250010
May 2025008
Jun 2025004
Total20590328